Chicago, IL. Nixon Peabody LLP represented leading life sciences company Laboratory Corporation of America Holdings (LabCorp) in its acquisition of U.K.-based contract research organization Chiltern International Ltd (Chiltern) for $1.2B.
Through this acquisition, LabCorp will grow its Drug Discovery Division and expand its global operations and customer base. LabCorp's Drug Discovery Division will include more than 20,000 employees across the Americas, EMEA and Asia-Pacific.
Nixon Peabody’s deal team included partners David R. Brown, Ethan E. Trull and Isabelle De Smedt.